Kamada (KMDA)
Develops plasma-derived therapies and distributes biopharmaceutical products in Israel and the MENA region.
$8.75
vs last close−0.12 (−1.35%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 8.61% | 4.97M ADS | |
|---|---|---|---|
| 51 holders · as of Jun 30, 2026 | |||
| Insiders | 52.73% | 30.42M ADS | |
| 13 holders · as of Sep 17, 2026 | |||
| Other | 38.66% | 22.30M ADS | |
| remainder | |||
57.69M ADS as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
51 holders · 4.97M shares · 12 new positions · 23 increased · 20 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Phoenix Holdings Ltd. | 1.65M | 2.87% | 0 | Aug 11, 2026 |
| Renaissance Technologies LLC | 742.4K | 1.29% | −20.5K | Aug 13, 2026 |
| Wells Fargo & Company/MN | 592.1K | 1.03% | −5.2K | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 301.7K | 0.52% | +301.7Knew | Aug 11, 2026 |
| Ark Investment Management LLC | 263.3K | 0.46% | −6.3K | Aug 14, 2026 |
| Huntleigh Advisors, Inc. | 162.6K | 0.28% | +7.2K | Aug 4, 2026 |
| Acadian Asset Management LLC | 154.4K | 0.27% | −217.2K | Aug 13, 2026 |
| Two Sigma Investments, LP | 151.1K | 0.26% | −43.1K | Aug 14, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 14, 2026 | David Tsurdirector | Sale | 22,827 | $8.18 | 407,929 |
| Sep 9, 2026 | David Tsurdirector | Sale | 175 | $8.26 | 430,756 |
| Sep 8, 2026 | David Tsurdirector | Sale | 162,760 | $8.26 | 430,931 |
| Sep 7, 2026 | David Tsurdirector | Sale | 14,238 | $8.28 | 593,691 |
House and Senate disclosures
Not reported.